About 200 thousand doses of the Russian vaccine against coronavirus infection “EpiVacCorona” entered the civil circulation. Tatyana Nepomnyashchikh, deputy head of the Vector Center of Rospotrebnadzor, spoke about this on March 30.
Nepomnyashchikh also made a forecast about future vaccine production volumes.
“Already about 200 thousand have gone into civil circulation. In April this value will be 1.5 million doses, in May – 3 million and 5 million by the middle of the year every month. Of course, our industrial partners are helping us to achieve such volumes, ”RT quotes her.
Also in Rospotrebnadzor noted that interest in “EpiVacCorona” is also shown abroad. The department has already received several dozen letters with requests and proposals.
In addition, Nepomnyashchikh said that the vaccine of the “Vector” center is one-component, but is administered in two injections with a difference of three weeks.
“Both shots, both vaccinations – they are the same. Immunity is formed approximately 21 days after the second vaccination. 42 days after the first vaccination. During this time, a person, of course, must be very careful not to get sick, he is not yet protected, “Nepomnyashchikh clarified.
Earlier, on March 26, the press service of Rospotrebnadzor said that EpiVacCorona helps to form a triple immune defense. The first line of defense is formed by antibodies that interfere with the interaction of the S-protein of the coronavirus with the cell receptor.
The second line of defense consists in antibodies that interfere with the fusion of the viral envelope with the cell membrane, thereby preventing the virus from entering the cell. The third mechanism starts working when the coronavirus enters the cell. Antibodies that recognize the proteins of the virus provoke the activity of special immune cells, and they destroy the infected cells.
On March 23, Russian Deputy Prime Minister Tatyana Golikova said that talk about the alleged ineffectiveness of the EpiVacCorona COVID-19 vaccine had no basis. Earlier, Golikova reported that she took root from the coronavirus with this particular drug.
On October 14, Russian President Vladimir Putin announced the registration in the country of the second vaccine against COVID-19 – a drug from the Vector Center, EpiVacCorona. Also in the Russian Federation were registered drugs “Sputnik V” and “KoviVac”.